Swedish medical device company Bactiguard AB (STO:BACTIB) announced on Friday a new distribution agreement with Schülke & Mayr GmbH (schülke), a German provider of infection prevention and hygiene solutions.
Under the agreement schülke will distribute Bactiguard's range of wound care solutions to German hospitals.
This collaboration enables schülke to complement its comprehensive product range of antiseptic and wound care products with Bactiguard's hypochlorous acid-based portfolio.
The German launch is scheduled for the third quarter of 2021.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system